Book a Meeting

Anti-CCL21 Antibody, Non-Fucosylated (BioBet-631ZP) (CAT#: BioBet-631ZP) Datasheet

Target
CCL21
Isotype
IgG
Description
ADCC-Enhanced anti-CCL21 (MOR08389) is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform.
Antibody Indication
Inflammatory Diseases
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced CCL21 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
CCL21
Full Name
chemokine (C-C motif) ligand 21
Background
This antimicrobial gene is one of several CC cytokine genes clustered on the p-arm of chromosome 9. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. Similar to other chemokines the protein encoded by this gene inhibits hemopoiesis and stimulates chemotaxis. This protein is chemotactic in vitro for thymocytes and activated T cells, but not for B cells, macrophages, or neutrophils. The cytokine encoded by this gene may also play a role in mediating homing of lymphocytes to secondary lymphoid organs. It is a high affinity functional ligand for chemokine receptor 7 that is expressed on T and B lymphocytes and a known receptor for another member of the cytokine family (small inducible cytokine A19).
Alternative Names
CCL21; chemokine (C-C motif) ligand 21; ECL; SLC; CKb9; TCA4; 6Ckine; SCYA21; C-C motif chemokine 21; beta chemokine exodus-2; secondary lymphoid tissue chemokine; Efficient Chemoattractant for Lymphocytes; small inducible cytokine subfamily A (Cys-Cys), member 21
Gene ID
Cellular Localization
Extracellular region or secreted
Involvement in Disease
Diseases associated with CCL21 include Gastric Lymphoma and Sjogren Syndrome.
Related Pathways
Its related pathways are Signaling by GPCR and PEDF Induced Signaling.
Function
Inhibit hematopoiesis and stimulate chemotaxis. Chemotaxis in vitro is ineffective against thymocytes and activated T cells, but not against b cells, macrophages or neutrophils. Shows preferential activity on naive T cells. May play a role in mediating the homing of lymphocytes to secondary lymphoid organs. Binds to the atypical chemokine receptor ACKR4 and mediates the recruitment of -arrestin (ARRB1/2) to ACKR4.
Post-translational modifications
1.Modification sites at neXtProt 2.Modification sites at PhosphoSitePlus
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG
Antibody Clone
MOR08389
Host
Human
Species Reactivity
Human
Description
The antibody binding to human CCL21 (hCCL21) can be used in the treatment and/or prevention of human diseases and disorders, particularly those of a fibrotic nature.
Antibody Indication
Inflammatory Diseases

Inflammatory Diseases

Related Products

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.